Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL (Q84779979)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

15

J Holowiecki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1

S Giebel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Slawomira Kyrcz-Krzemien

14

object named as

S Kyrcz-Krzemien

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

9

A B Skotnicki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Beata Stella-Hołowiecka

2

object named as

B Stella-Holowiecka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

Małgorzata Krawczyk-Kulis

11 February 2020

3

object named as

M Krawczyk-Kulis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

N Gökbuget

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

D Hoelzer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

M Doubek

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

J Mayer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

B Piatkowska-Jakubas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

H Dombret

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

P P Piccaluga

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

T Czerw

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Study Group for Adult ALL of the European Leukemia Net

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

26 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

1095-1101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855438%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2009.308

11 February 2020

exact match

0 references

cites work

How I treat acute lymphocytic leukemia in adults

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

G-CSF administered in time-sequenced setting during remission induction and consolidation therapy of adult acute lymphoblastic leukemia has beneficial influence on early recovery and possibly improves long-term outcome: a randomized multicenter stud

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021

In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: implications for autologous BMT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.308

7 January 2021